Genetic differences associated with dopamine and serotonin release mediate fear-induced bradycardia in the human brain

Simone Battaglia,Claudio Nazzi,Julian F. Thayer
DOI: https://doi.org/10.1038/s41398-024-02737-x
2024-01-16
Translational Psychiatry
Abstract:Fear-induced bradycardia, a transient heartbeat deceleration following exposure to threat, is a physiological index observable in humans, especially in fear conditioning experiments. While gaining interest in recent years, it is still currently underemployed in neuroscientific research compared to more popular physiological indices. Besides its use in research, it could also constitute a valuable resource in a clinical psychiatry setting, as many disorders are also characterized by altered heart rate responses. However, differences in fear-induced bradycardia may also be subtended by genetic interindividual differences, thus suggesting precaution when recommending its use in the clinical setting. Here, we discussed the first endeavors that aimed at clarifying the genetic underpinnings of heart rate variations, which suggest that individual genetic differences have a role in defining the characteristics of heart rate responses. Given this, translating heart rate measurements in the clinical setting must be implemented with caution. Future endeavors in this field will aim at identifying these differences even further, thus allowing for more precise clinical interventions.
psychiatry
What problem does this paper attempt to address?
The paper primarily explores how genetic differences related to dopamine and serotonin release mediate fear-induced bradycardia in the human brain. The paper points out that fear-induced bradycardia is a phenomenon where the heart rate slows down after exposure to threatening stimuli, used as a physiological indicator in neuroscience research. Although this phenomenon has attracted researchers' interest in recent years, it is still less used in neuroscience and psychiatry research compared to other more popular physiological indices. The paper emphasizes that due to the existence of genetic individual differences, the manifestation of fear-induced bradycardia may vary. Therefore, caution is needed when using it as a clinical tool. The authors discuss several preliminary studies that suggest genetic differences between individuals indeed affect the characteristics of heart rate responses. Based on these findings, future research will further identify these genetic differences, making clinical interventions more precise. Specifically, researchers found through experiments that: 1. Different variations of the **serotonin transporter gene** (5-HTT) affect the manifestation of fear-induced bradycardia. Individuals carrying the short allele (S) exhibit a stronger heart rate slowdown, while those carrying the long allele (L) do not show this significant change. 2. Single nucleotide polymorphisms in the **dopamine-metabolizing enzyme gene** (COMT) also affect the extinction process of fear memory. Individuals with the Val/Val genotype perform better in fear memory extinction. In summary, the paper aims to highlight the impact of genetic differences on fear-induced bradycardia and reminds that these factors should be carefully considered in clinical applications.